Andrew D. RuskinPartnerK&L GatesWebsitewww.klgates.comOrganization ProfileFull ProfileConnectEmailTwitterLinkedIn202-778-9415 Professional Biography Andrew Ruskin is a partner in the firm’s Washington, D.C. office. He is a member of the health care and FDA practice group. Areas of Focus Health Care and FDA Food, Drugs, Medical Devices, and Cosmetics (FDA) More Legal and Business Bylines From Andrew D. Ruskin 340B Update: Delaware Court Denies 340B Program Statute Requiring Contract Pharmacy Arrangements - (Posted On Wednesday, July 07, 2021) 340B Update: Federal Court Halts 340B Administrative Dispute Resolution Rule - (Posted On Monday, March 29, 2021) Hospitals Ask Supreme Court to Reverse Site-Neutral, 340B Payment Rulings - (Posted On Thursday, March 25, 2021) 340B Drug Pricing Program 2021 Outlook [PODCAST] - (Posted On Friday, March 19, 2021) COVID-19: Reimbursement Corner: Graduate Medical Education Gets Major Boost From Congressional Appropriations Bill - (Posted On Wednesday, December 23, 2020) 340B Update: HRSA Moves Forward with 340B ADR Rule as Covered Entities Challenge Contract Pharmacy Actions [PODCAST] - (Posted On Thursday, December 03, 2020) OIG Finalizes Rebate Rules: Removal of Safe Harbor Protections for Rebates and Creation of New Safe Harbors for Other Discounts and Service Fees - (Posted On Wednesday, December 02, 2020) 340B Update: Ryan White Clinics Sue in Response to Contract Pharmacy Actions as Congress Requests Information on Ways to Improve the 340B Program - (Posted On Friday, October 16, 2020) CMS'S Proposed Phase-Out of the Inpatient Only List is not Entirely Welcome News - (Posted On Tuesday, September 29, 2020) 340B UPDATE: Congress and the Administration Respond to Drug Manufacturers' 340B Contract Pharmacy Actions - (Posted On Saturday, September 26, 2020) Pagination Previous page ‹ Previous Page 2 Next page Next › Current Legal Analysis Supreme Court Vacates and Remands IRS Tax Whistleblower Case Following Reversal of Chevron by: Whistleblower Law at Kohn Kohn Colapinto The Never-Ending Fiduciary Rule Story Continues: Effective Date of DOL’s Newest Fiduciary Investment Advice Rule Delayed by Federal Court in Texas by: Adam W Scoll Bipartisan House Working Group Releases Report Calling for Increased Oversight of AI in the Financial Services and Housing Markets – AI: The Washington Report by: Bruce D. Sokler , Alexander Hecht Beltway Buzz, July 26, 2024 by: James J. Plunkett Weekly IRS Roundup July 15 – July 19, 2024 by: Evan Walters , Kevin Spencer OFCCP Releases Expedited Conciliation Procedures Directive by: Laura A. Mitchell Upcoming Legal Education Events Oct 23 2024 33rd Annual Law of Product Distribution and Franchise Seminar Oct 9 2024 Government Contracts Annual Update 2024 Sep 6 2024 Public Company Shareholder Engagement Summit Sep 6 2024 2024 Employment Law Symposium Print